4
Changes in Ownership
Dare Bioscience, Inc. Filed Acc 0001209191-17-002984
Options or other derivatives
- SVP, Chief Medical Officer acquired 210,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Senderowicz Adrian SVP, Chief Medical Officer | 2017-01-05 | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | D: show line 1 in the form | ||
| Senderowicz Adrian SVP, Chief Medical Officer | 2017-01-05 | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…